Similar content being viewed by others
This article is cited by
-
Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer
Cell Death Discovery (2023)
-
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers
npj Precision Oncology (2023)
-
Position paper on CDK4/6 inhibitors in early breast cancer
memo - Magazine of European Medical Oncology (2023)